Nuclear Antigen anticorps
-
- Antigène Voir toutes Nuclear Antigen (IPO-38) Anticorps
- Nuclear Antigen (IPO-38)
- Reactivité
- Humain, Souris, Rat
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp Nuclear Antigen est non-conjugé
-
Application
- Immunohistochemistry (IHC)
- Fonction
- Mouse anti-Human/Mouse/Rat IPO-38 Antibody (Proliferation Marker) [IHC only]
- Specificité
- Nuclear
- Purification
- Spleen cells from a patient with hairy cell leukemia were used as the immunogen for the IPO-38 antibody.
- Immunogène
- Spleen cells from a patient with hairy cell leukemia were used as the immunogen for the IPO-38 antibody.
- Top Product
- Discover our top product IPO-38 Anticorps primaire
-
-
- Indications d'application
- Prediluted format : incubate for 30 min at RT (2)
- Restrictions
- For Research Use only
-
- Buffer
- Prediluted in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide, For IHC use only
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
- Antigène
- Nuclear Antigen (IPO-38)
- Autre désignation
- IPO38 (IPO-38 Produits)
- Sujet
-
Target Description: Recognizes a protein of 14-16 kDa, which is a novel nuclear antigen of proliferating cells. IPO38 antigen is present in the nuclei of proliferating cells such as Hodgkin s disease and non-Hodgkin s lymphomas, different forms of leukemias, breast and colorectal carcinomas, and PHA-stimulated lymphocytes. It is not expressed in the cells of non-stimulated lymphocytes and granulocytes. IPO38 may be a useful marker of cell proliferation during monitoring of tumor progression.
-